Associations between proximity to gas production activity in counties and birth outcomes across the US

A Narrative Review of Spatial-Temporal Data Sources for Estimating Population-Level Exposures to Oil and Gas Development in the United States

PURPOSE OF REVIEW

Oil and gas development is a rapidly expanding industry that may impact population health. However, much of the research to date is conducted state-by-state, partially due to exposure data limitations. New developments related to national-scale oil and gas development data sources offer the opportunity to extend studies beyond single-state analyses. We review the current data options, highlighting their advantages, disadvantages, and ideal use-cases.

RECENT FINDINGS

Five data sources suitable for national-scale epidemiologic analyses of oil and gas development were identified. Private sector data offer detailed production information but have limited accessibility. Nongovernmental sources are often specialized, focusing on specific aspects like chemical or methane exposure. Government agency data, while typically less detailed, provide useful linkage tools for cross-industry analysis. This review clarifies the strengths and limitations of these sources, facilitating national-level exposure assessment and broadening the geographic reach of oil and gas development-related epidemiology in the U.S.

The human health effects of unconventional oil and gas development (UOGD): A scoping review of epidemiologic studies

OBJECTIVE

Unconventional oil and gas development (UOGD, sometimes termed "fracking" or "hydraulic fracturing") is an industrial process to extract methane gas and/or oil deposits. Many chemicals used in UOGD have known adverse human health effects. Canada is a major producer of UOGD-derived gas with wells frequently located in and around rural and Indigenous communities. Our objective was to conduct a scoping review to identify the extent of research evidence assessing UOGD exposure-related health impacts, with an additional focus on Canadian studies.

METHODS

We included English- or French-language peer-reviewed epidemiologic studies (January 2000-December 2022) which measured exposure to UOGD chemicals directly or by proxy, and where health outcomes were plausibly caused by UOGD-related chemical exposure. Results synthesis was descriptive with results ordered by outcome and hierarchy of methodological approach.

SYNTHESIS

We identified 52 studies from nine jurisdictions. Only two were set in Canada. A majority (n = 27) used retrospective cohort and case-control designs. Almost half (n = 24) focused on birth outcomes, with a majority (n = 22) reporting one or more significant adverse associations of UOGD exposure with: low birthweight; small for gestational age; preterm birth; and one or more birth defects. Other studies identified adverse impacts including asthma (n = 7), respiratory (n = 13), cardiovascular (n = 6), childhood acute lymphocytic leukemia (n = 2), and all-cause mortality (n = 4).

CONCLUSION

There is a growing body of research, across different jurisdictions, reporting associations of UOGD with adverse health outcomes. Despite the rapid growth of UOGD, which is often located in remote, rural, and Indigenous communities, Canadian research on its effects on human health is remarkably sparse. There is a pressing need for additional evidence.